X stock: buy or sell?

XBIT stock price: $14.07 -1.61% At close on February 21st, 2020

Updated on:
February 21st, 2020

1

Shares of XBiotech depreciated a fatal -1.61% and closed at $14.07. With Friday it's been 5 sliding days in a row, loosing $-2.46 (-11.28%). On February/14 XBIT plunged a bloodcurdling -9.76%.

XBiotech Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing True Human monoclonal antibodies for treating various diseases.

Should I buy X stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. That's why is so important to define your own trading strategy that matches with your character as inversor. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with XBiotech stock situation right now, hence this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean XBIT will fall in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is X stock a buy?

Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness. Unfortunately, we couldn't detect any rating for XBIT stock for the last 30 days.

X stock analysis

Daily outlook

X shares depreciated -1.61% to $14.07 today.

X ended today at $14.07 and depreciated a fatal -1.61%. Since SMA100d and SMA200d crossed up on November, XBIT price slid a -0.57%. For the last 7 days when XBIT stock price broke down the SMA100d line, it slid $-2.46 per share (-14.88%).

XBIT stock chart (daily)

Weekly outlook

X shares collapsed -6.57% this week, ending at $14.07. By mid January XBIT boosted an extraordinary 25.02% in just one week. With this, it's been 5 red weeks in a row, sliding $-10.23 or a -56.15%.

XBiotech shares slid under the support line what triggered further losses. Possible next supports for XBIT stock are 11.937 and 10.57. Since SMA20d and SMA40w crossed up by mid November 2019, XBIT price climbed $1.54 per share (12.29%). Since price and SMA40w lines crossed up by mid August 2019, XBIT climbed $6.98 (98.45%).

XBIT stock chart (weekly)

X stock price history

X stock went public on April 15th, 2015 with a price of $23.001. Since then, XBIT stock sliced a -38.80%, with a yearly average of -9.70%.

1: Adjusted price after possible price splits or reverse-splits.

X stock historical price chart

XBIT stock reached 52-week highs on Jan/14 at $26.40, and all-time highs 2015-04-21 with a price of 32.5.

X stock price target

Nobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we have not detected any price prediction for X stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

Since March, when XBiotech presented its last earnings report, it . Unfortunately, reported EPS is not yet available in our database.
XBIT earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a-0.32n/a
2017-Q2-n/a-0.26n/a
2017-Q3-n/a-0.18n/a
2017-Q42018-04-05n/an/an/a
2018-Q12018-06-27n/an/an/a
2018-Q22018-10-02n/an/an/a
2018-Q32018-10-31n/a-0.14n/a
2018-Q42019-03-29n/an/an/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

Compared to , last anual turnover report draw of to million USD. When comparing vs , , profit margin (that is, the net income divided by revenues) a to .

XBIT annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY

Quarterly financial results

Reported quarter income marked $-6.11 M with a profit margin of . Profit margin stayed constant a 0.00% compared to previous quarter when profit margin was inf%. When comparing revenues to same quarter last year, XBiotech sales marked a tight move and remained stable a nan%. Looking back to recent quarterly results, XBiotech posted 7 negative quarters in a row.
XBIT quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2

X ownership

When you are planning to buy shares of a stock, it's always worth to have a look its ownership structure.

XBiotech shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 39.54% of all shares.

In case of XBiotech stock, 25.03% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for XBIT stock account 0.00%, no big difference from last month.

For a better context understanding, the next table shows ownership data compared to other related companies:

XBIT
Market cap$578.1 M
Total shares41.1 M
Float shares25.4 M
  - Institutional holdings (%)25.0%
  - Insider holdings (%)39.5%
Shares in short selling0.0%

X summary

Friday, February 21st, 2020
Open$14.17
Close$14.07
Day range$13.83 - $14.56
Previous close$14.30
Session gain-1.61%
Average true range$1.14
50d mov avg$20.18
100d mov avg$15.51
200d mov avg$11.81
Daily patternlt03c
Weekly pattern lt06c

X performance

To measure stock performance is always good to benchmark with competitors or related stocks. We picked as the bechmarking frame for X stock.
Stock3m6m12m
XBITXBiotech9.49%71.17%65.33%

X competitors

Unfortunately, we could not find any public company that could be defined as X competitor. This doesn't mean X does not have any competitor in the market, it's just we could not detected it.